DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20220309
Published: 2022-01-29

Forens(om)ic medicine: omics in forensic medicine

Rajeev Goel, Deepak Kumar, Vijay Arora

Abstract


The branch of science informally known as ‘omics’ are various branches in biology whose names end in the suffix omics such as proteomics, metabolomics, genomics, transcriptomics. The studies regarding the role of omics in various branches of medical field have become an upcoming area and its rising trend has been observed in the last decade. Omics has very recently emerged as an uprising field in forensic medicine also which is already known for its great participation with other branches like forensic toxicology, biochemistry, psychiatry, genetics. The use of state- of-the-art omics technologies has been explored in forensic medicine and sciences in establishing post mortem interval, drugs of abuse, intoxication and cause of death. The various forensic studies presently are aiming omics for future prospective. An elementary attempt has been made in this review article to briefly present the role and advantages of omics in forensic medicine. We, hereby, propose to call it forensomic medicine, to draw attention of the forensic professionals to this novel branch of science in order to encourage new studies to be used in medico legal applications.


Keywords


Omics, Post mortem interval, Biomarkers, Toxicology, Drugs of abuse, Spectroscopy

Full Text:

PDF

References


Yadav SP. The wholeness in suffix -omics, -omes, and the word om. J Biomolecul Techniq. 2007;18(5):277.

Akcan R, Tasketin B, Yildirim MS, Aydogan HC, Sağlam N. Omics era in forensic medicine. Turk J Med Sci. 2020;50(5):1480-90.

Kuska B. Beer, Bethesda, and biology: how “genomics” came into being. J Nat Cancer Instit. 1998;90(2):93.

Laperche S, Vanhuffel V, Rauger P, Salmon C. Restriction fragment study of DNA polymorphism in criminology. Bulletin de la Societe Nationale de Transfusion Sanguine. 1991;34(2):139-50.

Nakanishi H, Shojo H, Ohmori T, Hara M, Takada A, Adachi N, et al. Identification of feces by detection of Bacteroides genes. Forensic Sci Int Genet. 2013;7(1):176-9.

Pechal JL, Crippen TL, Tarone AM, Lewis AJ, Tomberlin JK, Benbow ME. Microbial community functional change during vertebrate carrion decomposition. PLoS One. 2013;8(11):79035.

Castillo-Peinado LS, Castro MD. Present and foreseeable future of metabolomics in forensic analysis. Analytica Chimica Acta. 2016;925:1-15.

Johnson LA, Ferris JAJ. Analysis of postmortem DNA degradation by single-cell gel electrophoresis. Foren Sci Int. 2002;126:43-7.

Poor VS, Lukacs D, Nagy T, Rácz E, Sipos K. The rate of RNA degradation in human dental pulp reveals post-mortem interval. Int J Legal Med. 2016;130(3):615-9.

Sallee FR, DeVane CL, Ferrell RE. Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency. J Child Adolesc Psychopharmacol. 2000;10(1):27-34.

Wong SHY, Happy C, Blinka D, Gock S, Jentzen JM, Hon JD, et al. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system. Pharmacogenomics. 2010;11(6):731-7.

Tester DJ, Ackerman MJ. The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol. 2006;21(3):166-72.

Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner’s cases. Mayo Clinic Proceed. 2004;79(11):1380-4.

Lowe R, Shirley N, Bleackley M, Dolan S, Shafe T. Transcriptomics technologies. PLoS Comput Biol. 2017;13(5).

Takamiya M, Saigusa K, Nakayashiki N. Studies on mRNA expression of basic fibroblast growth factor in wound healing for wound age determination. Int J Legal Med. 2003;117(1):46-50.

Maeda H, Ishikawa T, Michiue T. Forensic molecular pathology: its impacts on routine work, education and training. Legal Med (Tokyo, Japan). 2014;16(2):61-9.

Oehmichen M, Lagodka T, Cröpelin A. RNA and DNA Synthesis of Epidermal Basal Cells after Wounding. Comparison of vital and postmortem investigations. Experiment Toxicol Pathol. 1997;49(3-4):233-7.

Ramaker RC, Bowling KM, Lasseigne BN, Hagenauer MH, Hardigan AA, Davis NS, et al. Post-mortem molecular profiling of three psychiatric disorders. Genome Med. 2017;9(1):72.

Miller JA, Ding SL, Sunkin SM. Transcriptional landscape of the prenatal human brain. Nature. 2014;508(7495):199-206.

Hanash S. Disease proteomics. Nature. 2003;422:226-32.

Vlahou A, Fountoulakis M. Proteomic approaches in the search for disease biomarkers. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;814(1):11-9.

Cristoni S, Bernardi LR. Development of new methodologies for the mass spectrometry study of bioorganic macromolecules. Mass Spectr Rev. 2003;22(6):369-406.

Liu Z, Yuan Z, Zhao Q. SELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects. PLoS One. 2014;9(7):103276.

Trenchevska O, Nelson RW, Nedelkov D. Mass spectrometric immunoassays in characterization of clinically significant proteoforms. Proteomes. 2016;4(1).

Virkler K, Lednev IK. Analysis of body fluids for forensic purposes: from laboratory testing to non-destructive rapid confirmatory identification at a crime scene. Forensic Sci Int. 2009;188(1-3):1-17.

Pittner S, Monticelli FC, Pfisterer A, Zissler A, Sänger AM, Stoiber W, et al. Postmortem degradation of skeletal muscle proteins: a novel approach to determine the time since death. Int J Legal Med. 2016;130(2):421-31.

Pittner S, Ehrenfellner B, Monticelli FC, Zissler A, Sänger AM, Stoiber W, et al. Postmortem muscle protein degradation in humans as a tool for PMI delimitation. Int J Legal Med. 2016;130(6):1547-55.

Procopio N, Williams A, Chamberlain AT, Buckley M. Forensic proteomics for the evaluation of the post-mortem decay in bones. J Proteomics. 2018;177:21-30.

Broadbelt KG, Rivera KD, Paterson DS. Brainstem deficiency of the 14-3-3 regulator of serotonin synthesis: a proteomics analysis in the sudden infant death syndrome. Molecul Cell Proteomics. 2012;11(1).

Palmiere C, Comment L, Vilarino R, Mangin P, Bonetti LR. Measurement of beta tryptase in postmortem serum in cardiac deaths. J Forensic Legal Med. 2014;23:12-8.

Unkrig S, Hagemeier L, Madea B. Postmortem diagnostics of assumed food anaphylaxis in an unexpected death. Forensic Sci Int. 2010;198(1-3):1-4.

Mustafa FB, Ng FSP, Nguyen TH, Lim LHK. Honeybee venom secretory phospholipase A2 induces leukotriene production but not histamine release from human basophils. Clin Experiment Immunol. 2008;151(1):94-100.

Bingol K. Recent advances in targeted and untargeted metabolomics by NMR and MS/NMR Methods. High Throughput. 2018;7(2):9.

Dunn W, Ellis D. Metabolomics: current analytical platforms and methodologies. Trend Analy Chem. 2005;24(4):285-94.

Carter DO, Yellowlees D, Tibbett M. Cadaver decomposition in terrestrial ecosystems. Naturwissenschaften. 2007;94(1):12-24.

Pechal JL, Crippen TL, Tarone AM. Microbial community functional change during vertebrate carrion decomposition. PLoS One. 2013;8(11):79035.

Castillo-Peinado LS, Castro MD. Present and foreseeable future of metabolomics in forensic analysis. Analytica Chimica Acta. 2016;925:1-15.

Hirakawa K, Koike K, Uekusa K, Nihira M, Yuta K, Ohno Y, et al. Experimental estimation of postmortem interval using multivariate analysis of proton NMR metabolomic data. Legal Med. 2009;11(1):282-5.

Sato T, Zaitsu K, Tsuboi K, Nomura M, Kusano M, Shima N, et al. A preliminary study on postmortem interval estimation of suffocated rats by GC-MS/MS-based plasma metabolic profiling. Analy Bioanaly Chem. 2015;407(13):3659-65.

Kang YR, Park YS, Park YC. UPLC/ Q-TOF MS based metabolomics approach to post-mortem interval discrimination: mass spectrometry based Metabolomics approach. J Pharmaceut Invest. 2012;42(1):41-6.

Donaldson AE, Lamont IL. Estimation of post-mortem interval using biochemical markers. Austral J Forensic Sci. 2014;46(1):8-26.

Vinamaki J, Rasanen L, Vuori E, Ojanperä I. Elevated formic acid concentration in putrefied post-mortem blood and urine samples. Forensic Sci Int. 2011;208(1-3):42-6.

Donaldson AE, Lamont IL. Biochemistry changes that occur after death: potential markers for determining post-mortem interval. PloS One. 2013;8(11):82011.

Holmes E, Loo RL, Cloarec O. Detection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy. Analytical Chem. 2007;79(7):2629-40.

Tsai IL, Weng TI, Tseng YJ. Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatographyquadrupole time-of-flight mass spectrometry. J Analyt Toxicol. 2013;37(9):642-51.

Krumbiegel F, Hastedt M, Tsokos M. Nails are a potential alternative matrix to hair for drug analysis in general unknown screenings by liquid-chromatography quadrupole time-of-flight mass spectrometry. Forensic Sci Med Pathol. 2014;10(4):496-503.

Michell AW, Mosedale D, Grainger DJ, Barker A. Metabolomic analysis of urine and serum in Parkinson’s disease. Metabolomics. 2008;4(3):191-201.

Varma VR, Oommen AM, Varma S. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study. PLoS Med. 2018;15(1):1002482.

Favretto D, Cosmi E, Ragazzi E, Visentin S, Tucci M, Fais P, et al. Cord blood metabolomic profiling in intrauterine growth restriction. Analytical and Bioanalyt Chem. 2012;402(3):1109-21.

Kenny LC, Dunn WB, Ellis DI, Kell DB. Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning. Metabolomics. 2005;1(3):227-34.

Cecchi R. Diagnosis of anaphylactic death in forensics: review and future perspectives. Legal Med. 2016;22:75-81.

Ghauri FY, Nicholson JK, Sweatman BC. NMR spectroscopy of human post mortem cerebrospinal fluid: distinction of Alzheimer’s disease from control using pattern recognition and statistics. NMR Biomed. 1993;6(2):163-7.

Hu X, Wu GP, Zhang MH, Pan SQ. GC-MS-based metabolic profiling reveals metabolic changes in anaphylaxis animal models. Analyt Bioanalyt Chem. 2012;404(3):887-93.